-
S426046-1mlanti-inflammatory and analgesic activities.
-
W417835-100mganti-inflammatory and analgesic activities.
-
W417835-10mganti-inflammatory and analgesic activities.
-
W417835-25mganti-inflammatory and analgesic activities.
-
W417835-50mganti-inflammatory and analgesic activities.
-
W417835-5mganti-inflammatory and analgesic activities.
-
-
S126117-100mgapplication:SU 11274 was used to inhibit c-Met in non-small cell lung cancer cell lines.3 SU11274 has been used: To study the role of hepatocyte growth factor (HGF) in human vestibular schwannoma proliferation. To study
-
S126117-10mgapplication:SU 11274 was used to inhibit c-Met in non-small cell lung cancer cell lines.3 SU11274 has been used: To study the role of hepatocyte growth factor (HGF) in human vestibular schwannoma proliferation. To study
-
S126117-250mgapplication:SU 11274 was used to inhibit c-Met in non-small cell lung cancer cell lines.3 SU11274 has been used: To study the role of hepatocyte growth factor (HGF) in human vestibular schwannoma proliferation. To study
-
S126117-25mgapplication:SU 11274 was used to inhibit c-Met in non-small cell lung cancer cell lines.3 SU11274 has been used: To study the role of hepatocyte growth factor (HGF) in human vestibular schwannoma proliferation. To study
-
S126117-50mgapplication:SU 11274 was used to inhibit c-Met in non-small cell lung cancer cell lines.3 SU11274 has been used: To study the role of hepatocyte growth factor (HGF) in human vestibular schwannoma proliferation. To study